Filing Details
- Accession Number:
- 0001179110-13-017173
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-27 15:37:07
- Reporting Period:
- 2013-11-25
- Filing Date:
- 2013-11-27
- Accepted Time:
- 2013-11-27 15:37:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1394777 | Hiroaki Shigeta | 8 Sylvan Way Parsippany NJ 07054 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-11-25 | 17,039 | $21.14 | 39,388 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-11-25 | 17,039 | $37.19 | 22,349 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (Right-to-buy) | Disposition | 2013-11-25 | 17,039 | $0.00 | 17,039 | $21.14 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2023-05-22 | No | 4 | M | Direct |
Footnotes
- The common stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 program adopted by Mr. Shigeta on October 25, 2013.
- The range of prices for the transactions reported on this line is between $36.59 and $37.72 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full informaton regarding the number of shares sold at each separate price.
- As of November 25, 2013, the original grant (17,039 shares granted on May 22, 2012) was fully vested and exercised.